Onderneming Werewolf Therapeutics, Inc.
Aandelen
HOWL
US95075A1079
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,84 USD | +4,10% | +10,40% | +51,30% |
Vakgebied
Aantal werknemers: 47
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Cancer Therapeutics
100,0
%
| 16 | 100,0 % | 20 | 100,0 % | +21,60% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 16 | 100,0 % | 20 | 100,0 % | +21,60% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dan Hicklin
FOU | Founder | 60 | 19-10-17 |
Luke Evnin
FOU | Founder | 60 | 19-10-17 |
Timothy Trost
DFI | Director of Finance/CFO | 66 | 08-02-21 |
Chief Tech/Sci/R&D Officer | - | 15-06-21 | |
Randi Isaacs
CTO | Chief Tech/Sci/R&D Officer | 68 | 01-11-20 |
Ellen Lubman
IRC | Investor Relations Contact | 48 | 01-08-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Luke Evnin
FOU | Founder | 60 | 19-10-17 |
Dan Hicklin
FOU | Founder | 60 | 19-10-17 |
Michael Sherman
BRD | Director/Board Member | 58 | 27-05-21 |
Briggs Morrison
BRD | Director/Board Member | 65 | 01-11-19 |
Alon Lazarus
BRD | Director/Board Member | 49 | 01-08-19 |
Derek DiRocco
BRD | Director/Board Member | 43 | 01-12-20 |
Director/Board Member | - | 04/01 | |
Meeta Chatterjee
BRD | Director/Board Member | 69 | 28-10-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 43 347 363 | 40 458 852 ( 93,34 %) | 0 | 93,34 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+51,30% | 243 mln. | |
-1,78% | 41,71 mld. | |
+47,70% | 41,56 mld. | |
+4,01% | 39,74 mld. | |
-15,14% | 25,61 mld. | |
+3,16% | 24,26 mld. | |
-24,08% | 18,55 mld. | |
-2,67% | 11,93 mld. | |
+24,76% | 11,93 mld. | |
+7,01% | 10,91 mld. |
- Beurs
- Aandelen
- Koers HOWL
- Onderneming Werewolf Therapeutics, Inc.